Cerebral cavernous malformations: Somatic mutations in vascular endothelial cells

Neurosurgery

Volumn 65, Issue 1, 2009, Pages 138-144

  Gault, Judith ^a,d   Awad, Issam A ^b   Recksiek, Peter ^a   Shenkar, Robert ^b   Breeze, Robert ^a   Handler, Michael ^a   Kleinschmidt DeMasters, Bette K ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NONE   (United States)

Author keywords

Genetics; Hemorrhagic; Mutation; Stroke; Vascular malformations

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR MALFORMATION; CHILD; FEMALE; GENE; HUMAN; HUMAN TISSUE; KRIT1 GENE; LASER CAPTURE MICRODISSECTION; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PDCD10 GENE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SOMATIC MUTATION; VASCULAR ENDOTHELIUM;

ADOLESCENT; APOPTOSIS REGULATORY PROTEINS; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; ENDOTHELIAL CELLS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POINT MUTATION; PROTO-ONCOGENE PROTEINS;

EID: 67651153055     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000348049.81121.C1     Document Type: Article

References (44)

1. Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA: Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): Evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18:919-930, 2009.
2. Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, Notaro R, Luzzatto L: A quantitative measurement of the human somatic mutation rate. Cancer Res 65:8111-8117, 2005. (Pubitemid 41330573)
3. Béraud-Dufour S, Gautier R, Albiges-Rizo C, Chardin P, Faurobert E: Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J 274:5518-5532, 2007. (Pubitemid 47622064)
4. Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E; Société Française de Neurochirurgie: Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76:42-51, 2005. (Pubitemid 40023764)
5. Clarke LA, Rebelo CS, Gonçalves J, Boavida MG, Jordan P: PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences. Mol Pathol 54:351-353, 2001. (Pubitemid 32928263)
6. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau JJ, Nivelon-Chevallier A, Parker F, Redondo AM, Scarabin JM, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E; Société Française de Neurochirurgie: Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74:326-337, 2004. (Pubitemid 38168620)
7. Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M, Maciazek J, Vicaut E, Brunereau L, Tournier-Lasserve E; Société Française de Neuro-chirurgie: Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 60:550-556, 2006. (Pubitemid 44871797)
8. Devuyst O: Variable progression of autosomal dominant polycystic kidney disease: Genetic and molecular counterparts [in French]. Nephrol Ther 2 [Suppl 2]:S104-S108, 2006. (Pubitemid 43156023)
9. Donohoe E: Denaturing high-performance liquid chromatography using the WAVE DNA fragment analysis system. Methods Mol Med 108:173-187, 2005.
10. Felbor U, Gaetzner S, Verlaan DJ, Vijzelaar R, Rouleau GA, Siegel AM: Large germline deletions and duplication in isolated cerebral cavernous malformation patients. Neurogenetics 8:149-153, 2007. (Pubitemid 46356248)
11. Friedman JM, Fialkow PJ, Greene CL, Weinberg MN: Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis. J Natl Cancer Inst 69:1289-1292, 1982.
12. Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA: Pathobiology of human cerebrovascular malformations: Basic mechanisms and clinical relevance. Neurosurgery 55:1-17, 2004. (Pubitemid 38859066)
13. Gault J, Shenkar R, Recksiek P, Awad IA: Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36:872-874, 2005. (Pubitemid 40490641)
14. Glading A, Han J, Stockton RA, Ginsberg MH: KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179:247-254, 2007. (Pubitemid 350004889)
15. Goudreault M, D'Ambrosio LM, Kean MJ, Mullin MJ, Larsen BG, Sanchez A, Chaudhry S, Chen GI, Sicheri F, Nesvizhskii AI, Aebersold R, Raught B, Gingras AC: A PP2A phosphatase high-density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics 8:157-171, 2008.
16. Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, Wu CC: Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 6:4343-4355, 2007. (Pubitemid 350158510)
17. Hogan BM, Bussmann J, Wolburg H, Schulte-Merker S: Ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum Mol Genet 17:2424-2432, 2008.
18. Jabbour P, Gault J, Murk SE, Awad IA: Multiple spinal cavernous malformations with atypical phenotype after prior irradiation: Case report. Neurourgery 55:1431, 2004. (Pubitemid 39612898)
19. Kehrer-Sawatzki H, Wilda M, Braun VM, Richter HP, Hameister H: Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol 104:231-240, 2002. (Pubitemid 36082782)
20. Knudson AG Jr: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823, 1971.
21. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E : Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189-193, 1999. (Pubitemid 29455391)
22. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA: Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-1464, 2003. (Pubitemid 38037437)
23. Liquori CL, Berg MJ, Squitieri F, Leedom TP, Ptacek L, Johnson EW, Marchuk DA: Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet 80:69-75, 2007. (Pubitemid 46047651)
24. Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, Cannella M, Maglione V, Ptacek L, Johnson EW, Marchuk DA: Low frequency of PDCD10 mutations in a panel of CCM3 probands: Potential for a fourth CCM locus. Hum Mutat 27:118, 2006.
25. Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G, Tang J, Ma D: TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254:203-210, 1999. (Pubitemid 29292042)
26. Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman MC: Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133:3139-3146, 2006.
27. Marini V, Ferrera L, Pigatto F, Origone P, Garrè C, Dorcaratto A, Viale G, Alberti F, Mareni C: Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients. Am J Med Genet A 130A:98-101, 2004. (Pubitemid 39121569)
28. Marusyk A, DeGregori J: Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta 1785:1-11, 2008. (Pubitemid 350192081)
29. Murphy SL, High KA: Gene therapy for haemophilia. Br J Haematol 140:479-487, 2008.
30. Ortiz L, Costa AF, Bellido ML, Solano F, García-Moreno JM, Gamero MA, Izquierdo G, Chadli A, Falcao F, Ferro J, Salas J, Alvarez-Cermeño JC, Montori M, Ramos-Arroyo MA, Palomino A, Pintado E, Lucas M: Study of cerebral cavernous malformation in Spain and Portugal: High prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene). J Neurol 254:322-326, 2007. (Pubitemid 46399192)
31. Pagenstecher A, Stahl S, Sure U, Felbor U: A two-hit mechanism causes cerebral cavernous malformations: Complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18:911-918, 2009.
32. Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA: Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol 165:1509-1518, 2004. (Pubitemid 39435151)
33. Reich P, Winkler J, Straube A, Steiger HJ, Peraud A: Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas. Neurology 60:1135-1138, 2003. (Pubitemid 36418774)
34. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA: Mutations in the gene encoding KRIT1, a Krev- 1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8:2325-2333, 1999. (Pubitemid 29525349)
35. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA: Association of Krev- 1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043-1049, 1997. (Pubitemid 27401958)
36. Tu J, Stoodley MA, Morgan MK, Storer KP: Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg 103:903-909, 2005. (Pubitemid 43194585)
37. Verlaan DJ, Roussel J, Laurent SB, Elger CE, Siegel AM, Rouleau GA: CCM3 mutations are uncommon in cerebral cavernous malformations. Neurology 65:1982-1983, 2005.
38. Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, Felbor U: CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 8:249-256, 2007. (Pubitemid 47624455)
39. Watnick T, He N, Wang K, Liang Y, Parfrey P, Hefferton D, St George-Hyslop P, Germino G, Pei Y: Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet 25:143-144, 2000. (Pubitemid 30394981)
40. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY: Ccm1 is required for arterial morphogenesis: Implications for the etiology of human cavernous malformations. Development 131:1437-1448, 2004.
41. Wong JH, Awad IA, Kim JH: Ultrastructural pathological features of cerebrovascular malformations: A preliminary report. Neurosurgery 46:1454-1459, 2000.
42. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA: KRIT1 association with the integrin-binding protein ICAP-1: A new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396, 2002.
43. Zhang J, Basu S, Rigamonti D, Dietz HC, Clatterbuck RE: Krit1 modulates β1- integrin-mediated endothelial cell proliferation. Neurosurgery 63:571-578, 2008.
44. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC: Interaction between krit1 and icap1á infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960, 2001. (Pubitemid 34030926)